Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study: Functional Treatment Planning Utilizing 18-FDGal PET/CT in SBRT for Liver Metastases

NCT01861873 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT01861873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01861873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study: Functional Treatment Planning Utilizing 18-FDGal PET/CT in SBRT for Liver Metastases
Lead sponsor
University of Aarhus
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2013
Completion date
March 31, 2016
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver metastases